Jasper Therapeutics, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2020 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Jasper Therapeutics, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2020 to Q2 2024.
  • Jasper Therapeutics, Inc. Operating Lease, Right-of-Use Asset for the quarter ending June 30, 2024 was $1.23M, a 26.9% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $1.23M -$454K -26.9% Jun 30, 2024 10-Q 2024-08-13
Q1 2024 $1.35M -$436K -24.4% Mar 31, 2024 10-Q 2024-05-14
Q4 2023 $1.47M -$419K -22.2% Dec 31, 2023 10-Q 2024-08-13
Q3 2023 $1.58M -$401K -20.3% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $1.69M -$385K -18.6% Jun 30, 2023 10-Q 2023-08-11
Q1 2023 $1.79M -$435K -19.6% Mar 31, 2023 10-Q 2023-05-12
Q4 2022 $1.89M +$739K +64.4% Dec 31, 2022 10-K 2024-03-05
Q3 2022 $1.98M +$797K +67.4% Sep 30, 2022 10-Q 2022-11-10
Q2 2022 $2.07M Jun 30, 2022 10-Q 2022-08-12
Q1 2022 $2.22M Mar 31, 2022 10-Q 2022-05-12
Q4 2021 $1.15M -$189K -14.1% Dec 31, 2021 10-K 2023-03-08
Q3 2021 $1.18M Sep 30, 2021 10-Q 2021-11-12
Q4 2020 $1.34M Dec 31, 2020 10-K 2022-03-18
* An asterisk sign (*) next to the value indicates that the value is likely invalid.